Brainstorm Cell Therapeutics Soars 45%

By: via Benzinga
Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) surged 45 percent in Friday’s premarket, adding to the stock’s gain of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.